Subtopic Deep Dive

Adverse Drug Reactions Monitoring
Research Guide

What is Adverse Drug Reactions Monitoring?

Adverse Drug Reactions Monitoring involves systematic detection, reporting, and analysis of unintended harmful effects from medications to enhance patient safety in clinical pharmacy practice.

This subtopic encompasses pharmacovigilance systems, causality assessment methods, and interventions to mitigate ADRs in hospital and community settings. Key studies focus on pharmacist interventions reducing readmissions and drug-related problems in geriatric patients, with over 20 papers from the provided list cited 50+ times each. Research highlights polypharmacy risks and clinical pharmacist roles in error prevention.

Curated Papers

Key Challenges

Why It Matters

Effective ADR monitoring directly reduces hospital readmissions, as shown in Ravn‐Nielsen et al. (2018) where multifaceted pharmacist interventions lowered readmission risks by 33% in a randomized trial (NCT03079375, 282 citations). In geriatrics, Hailu et al. (2020) demonstrated clinical pharmacists resolving 78% of drug-related problems, preventing adverse outcomes in polypharmacy cases (113 citations). These practices inform regulatory decisions and improve safety profiles for antineoplastic agents per Köhler et al. (2002) guidelines (120 citations), impacting millions of patients annually through reduced medication errors.

Key Research Challenges

Causality Assessment in Polypharmacy

Distinguishing ADRs from underlying diseases is difficult in elderly patients on multiple drugs, as DRPs increase with drug count (Hugtenburg et al., 2014, 104 citations). Current methods lack standardization for complex cases. Interventions must balance efficacy and risk without clear protocols.

Underreporting in Hospital Settings

Healthcare professionals underreport ADRs due to knowledge gaps and poor collaboration, leading to persistent errors in ICUs (Irajpour et al., 2017, 79 citations). Systems fail to capture post-discharge events. Automated detection tools are underdeveloped.

Scalability of Pharmacist Interventions

Multifaceted interventions reduce readmissions but strain resources in high-volume wards (Ravn‐Nielsen et al., 2018, 282 citations; Gustafsson et al., 2017, 61 citations). Training and integration into teams vary by region. Sustaining impact requires standardized education (Hu et al., 2014, 58 citations).

Essential Papers

Effect of an In-Hospital Multifaceted Clinical Pharmacist Intervention on the Risk of Readmission

Lene Vestergaard Ravn‐Nielsen, Marie-Louise Duckert, Mia Lolk Lund et al. · 2018 · JAMA Internal Medicine · 282 citations

clinicaltrials.gov Identifier: NCT03079375.

ASHP Guidelines on Preventing Medication Errors with Antineoplastic Agents

David Köhler, Michael Montello, Barry R. Goldspiel et al. · 2002 · American Journal of Health-System Pharmacy · 120 citations

Journal Article ASHP Guidelines on Preventing Medication Errors with Antineoplastic Agents Get access David R. Kohler, Pharm.D., David R. Kohler, Pharm.D. Search for other works by this author on: ...

Drug related problems in admitted geriatric patients: the impact of clinical pharmacist interventions

Berhane Yohannes Hailu, Derebew Fikadu Berhe, Esayas Kebede Gudina et al. · 2020 · BMC Geriatrics · 113 citations

Abstract Background Geriatric patients are at high risk of Drug Related Problems (DRPs) due to multi- morbidity associated polypharmacy, age related physiologic changes, pharmacokinetic and pharmac...

Identification of drug-related problems of elderly patients discharged from hospital

Jacqueline G. Hugtenburg, Abeer Ahmad, Ruth Mast et al. · 2014 · Patient Preference and Adherence · 104 citations

Following hospital discharge, DRP occur frequently among elderly patients using five or more drugs for the treatment of chronic disease. The number of DRP increased with the number of drugs used. A...

Causes of medication errors in intensive care units from the perspective of healthcare professionals

Alireza Irajpour, Sedigheh Farzi, Mahmoud Saghaei et al. · 2017 · Journal of Research in Pharmacy Practice · 79 citations

Incorrect prescribing of physicians, unsafe drug administration of nurses, the lack of pharmaceutical knowledge of the healthcare team, and the weak professional collaboration lead to medication er...

A review of studies using the Japanese National Database of Health Insurance Claims and Specific Health Checkups

Naoki Hirose, Miho Ishimaru, Kojiro Morita et al. · 2020 · Annals of Clinical Epidemiology · 73 citations

BACKGROUND

Pharmacist participation in hospital ward teams and hospital readmission rates among people with dementia: a randomized controlled trial

Maria Gustafsson, Maria Sjölander, Bettina Pfister et al. · 2017 · European Journal of Clinical Pharmacology · 61 citations

Reading Guide

Foundational Papers

Start with Köhler et al. (2002, 120 citations) for antineoplastic ADR prevention guidelines, then Hugtenburg et al. (2014, 104 citations) for elderly DRP identification post-discharge, and Agrawal et al. (2009, 60 citations) for medication error recommendations.

Recent Advances

Study Ravn‐Nielsen et al. (2018, 282 citations) for pharmacist intervention trial reducing readmissions, Hailu et al. (2020, 113 citations) for geriatric DRPs, and Gustafsson et al. (2017, 61 citations) for dementia ward impacts.

Core Methods

Core techniques are clinical pharmacist interventions (Ravn‐Nielsen et al., 2018), DRP screening in polypharmacy (Hailu et al., 2020; Hugtenburg et al., 2014), error prevention guidelines (Köhler et al., 2002), and educational protocols (Martin et al., 2013).

How PapersFlow Helps You Research Adverse Drug Reactions Monitoring

Discover & Search

Research Agent uses searchPapers and exaSearch to find high-citation ADR studies like Ravn‐Nielsen et al. (2018, 282 citations), then citationGraph reveals intervention clusters and findSimilarPapers uncovers geriatric DRP papers such as Hailu et al. (2020).

Analyze & Verify

Analysis Agent applies readPaperContent to extract ADR causality methods from Köhler et al. (2002), verifies intervention efficacy with verifyResponse (CoVe) against trial data (NCT03079375), and runs PythonAnalysis for statistical meta-analysis of readmission rates with GRADE grading for evidence strength.

Synthesize & Write

Synthesis Agent detects gaps in post-discharge monitoring via contradiction flagging across Hugtenburg et al. (2014) and Agrawal et al. (2009); Writing Agent uses latexEditText, latexSyncCitations for Ravn‐Nielsen et al., and latexCompile to generate ADR workflow diagrams with exportMermaid.

Use Cases

"Analyze readmission rates from pharmacist ADR interventions in geriatrics using stats."

Research Agent → searchPapers('geriatric ADR pharmacist intervention') → Analysis Agent → readPaperContent(Ravn‐Nielsen 2018 + Hailu 2020) → runPythonAnalysis(pandas meta-analysis of rates, matplotlib plots) → researcher gets CSV of risk reductions and GRADE-scored evidence.

"Write LaTeX review on antineoplastic ADR prevention guidelines."

Research Agent → citationGraph(Köhler 2002) → Synthesis Agent → gap detection → Writing Agent → latexEditText(draft sections) → latexSyncCitations(all papers) → latexCompile → researcher gets compiled PDF with synced bibliography and ADR flowcharts.

"Find open-source code for ADR causality assessment tools from papers."

Research Agent → exaSearch('ADR causality algorithm code') → Code Discovery → paperExtractUrls(Hugtenburg 2014) → paperFindGithubRepo → githubRepoInspect → researcher gets validated repos with Python scripts for DRP scoring.

Automated Workflows

Deep Research workflow conducts systematic reviews of 50+ ADR papers, chaining searchPapers → citationGraph → DeepScan for 7-step verification of intervention impacts like Ravn‐Nielsen et al. (2018). Theorizer generates hypotheses on scalable pharmacovigilance from Gustafsson et al. (2017) dementia trials. DeepScan applies CoVe checkpoints to validate polypharmacy risks in Hailu et al. (2020).

Try Doxa for Adverse Drug Reactions Monitoring Research

Frequently Asked Questions

What is Adverse Drug Reactions Monitoring?

It is the systematic process of detecting, assessing, understanding, and preventing adverse effects or other drug-related problems to ensure patient safety in pharmacy practice.

What are key methods in ADR monitoring?

Methods include multifaceted clinical pharmacist interventions (Ravn‐Nielsen et al., 2018), DRP identification at discharge (Hugtenburg et al., 2014), and guidelines for antineoplastic error prevention (Köhler et al., 2002).

What are the most cited papers?

Top papers are Ravn‐Nielsen et al. (2018, 282 citations) on readmission reduction, Köhler et al. (2002, 120 citations) on antineoplastic guidelines, and Hailu et al. (2020, 113 citations) on geriatric DRPs.

What are open problems in ADR monitoring?

Challenges include underreporting in ICUs (Irajpour et al., 2017), scalability of interventions (Gustafsson et al., 2017), and standardized causality assessment in polypharmacy (Hugtenburg et al., 2014).